Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
Open Access
- 12 November 2019
- journal article
- research article
- Published by Springer Nature in BMC Molecular and Cell Biology
- Vol. 20 (1) , 1-14
Abstract
Background: Several reports indicated that the expression of Yes-associated protein (YAP) was associated with multi-drug resistance. Acidic microenvironment increased by the overexpression of vacuolar-ATPase (V-ATPase) was also observed in tumor growth and drug resistance. We hypothesize that proton pump inhibitors (PPIs), currently used in the anti-acid treatment of peptic disease, could inhibit the acidification of the tumor microenvironment and increase the sensitivity of tumor cells to cytotoxic agents. Thus, our objective is to explore the reversal of drug resistance by the inhibition of YAP through specific PPIs in the epithelial ovarian carcinoma (EOC) cells. . Results: We found that V-ATPase D1 was a positive regulator of YAP. Sub-lethal doses of the proton pump inhibitor esomeprazole (EMSO) in combination with paclitaxel (PTX) increased the PTX sensitivity in PTX-resistant EOC cells, as compared to PTX single treatments by inhibiting YAP and reserving pH gradient created by the V-ATPase D1. Moreover, sub-lethal doses of EMSO combined with PTX decreased autophagy and improved caspases independent apoptosis of PTX-resistant EOC cells. Conclusions: These results suggested that sub-lethal doses of esomeprazole reverse YAP-mediated PTX resistance through the inhibiting of both YAP expression and acidic tumor microenvironment created by the V-ATPase D1. Therefore, we think the use of PPIs represents a promising strategy to improve the effectiveness of anti-EOC.Keywords
Funding Information
- National Natural Science Foundation of China (81603138)
- Special Fund for Guiding Local Science and Technology Development by the Central Government of Anhui Province (2017070802d149)
This publication has 42 references indexed in Scilit:
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bedJournal of Translational Medicine, 2013
- Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cellsOncology Letters, 2013
- Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer CellsPLOS ONE, 2011
- Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cellsCell Death & Disease, 2010
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategyJournal of Experimental & Clinical Cancer Research, 2010
- NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathwayOncogene, 2009
- Selective Induction of Apoptosis with Proton Pump Inhibitor in Gastric Cancer CellsClinical Cancer Research, 2004
- Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic DrugsJNCI: Journal of the National Cancer Institute, 2004
- The vacuolar (H+)-ATPases — nature's most versatile proton pumpsNature Reviews Molecular Cell Biology, 2002